News about Drug Discovery & Development

Kenox Pharmaceuticals Enhances Capabilities to Boost Drug Development

Kenox Pharmaceuticals Inc has expanded its capabilities with small-scale non-sterile GMP facilities to support GLP pre-clinical studies, reinforcing its commitment to accelerating the development of innovative Orally Inhaled and Nasal Drug Products (OINDPs).

Drug Discovery & Development | 29/01/2025 | By Manvi

FDA Grants Priority Review to Merck's Application for 'WELIREG'

Merck announced the US FDA has accepted for priority review a supplemental new drug application (sNDA) seeking approval of WELIREG® (belzutifan), Merck’s oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor, for the treatment of adult and and pediatric patients (12 years and older).

Drug Discovery & Development | 27/01/2025 | By Manvi

Glenmark Pharmaceuticals Unveils Generic Anticoagulant Injectable Emulsion

Glenmark's Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules is bioequivalent and therapeutically equivalent to the reference listed drug, Vitamin K1 Injectable Emulsion USP, 10 mg/mL of Hospira, Inc., ANDA 087955.

Drug Discovery & Development | 24/01/2025 | By Aishwarya

Catalyst Pharmaceuticals Announces Launch of FIRDAPSE in Japan by DyDo

FIRDAPSE (amifampridine) is the only US FDA approved, evidence-based therapy for the treatment of LEMS in adults and pediatric patients six years of age and older.

Drug Discovery & Development | 22/01/2025 | By Aishwarya

Absci and Owkin Partner to Propel Generative AI in Drug Discovery

Absci Corporation and Owkin announced a partnership bringing together two leading AI platforms to rapidly discover and design novel therapeutics for patients.

Drug Discovery & Development | 21/01/2025 | By Manvi

Iconovo and Lonza to Develop Formulation of Intranasal Biologic

This project, with a reformulated substance for obesity, is the first in Iconovo’s strategic initiative to reformulate known pharmaceuticals and replace injections and oral treatments with inhalation.

Drug Discovery & Development | 14/01/2025 | By Aishwarya

Absci Partners with AMD to Propel Future of AI Drug Discovery

AMD will also make a USD 20 million investment in Absci, structured as a private investment in public equity (PIPE), underscoring the growing demand for innovative AI applications in drug discovery.

Drug Discovery & Development | 10/01/2025 | By Aishwarya

Merck KGaA Adopts Quris-AI's Bio-AI Platform for its Drug Development Pipeline

Quris-AI’s drug safety prediction platform integrates advanced AI, machine learning, generative models, patient-on-chip technology, and proprietary data to predict potential drug- induced toxicities better.

Drug Discovery & Development | 09/01/2025 | By Aishwarya

Acellera Rolls Out AceForce 1.0 to Advance Drug Discovery

AceForce 1.0 is a groundbreaking tool in computational chemistry and drug discovery, offering quantum-level accuracy by leveraging a proprietary training set of millions of quantum mechanical (QM) calculations.

Drug Discovery & Development | 08/01/2025 | By Aishwarya

WuXi Biologics Signs Deal with Candid Therapeutics to Boost Trispecific T-cell Engager

Under the terms of the agreement, Candid will have exclusive global rights to a preclinical trispecific T-cell Engager discovered at WuXi Biologics' proprietary universal multispecific antibody platform WuXiBody.

Drug Discovery & Development | 07/01/2025 | By Aishwarya